Abbott Laboratories buy Wells Fargo & Company
Start price
17.04.25
/
50%
€116.02
Target price
17.04.26
€129.36
Performance (%)
-2.50%
Price
22.08.25
€113.12
Summary
This prediction is currently active. With a performance of -2.50%, the BUY prediction by Wells_Fargo___Compan is trending in the wrong direction. This prediction currently runs until 17.04.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 0.462% | 0.462% |
| iShares Core DAX® | -0.099% | 1.027% |
| iShares Nasdaq 100 | -1.085% | 2.134% |
| iShares Nikkei 225® | -0.835% | 8.556% |
| iShares S&P 500 | 0.099% | 2.881% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Wells Fargo & Company from $136.00 to $147.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€106.62
18.07.25
18.07.25
€122.15
18.07.26
18.07.26
6.10%
22.08.25
22.08.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€113.50
23.01.25
23.01.25
€130.57
23.01.26
23.01.26
-0.33%
22.08.25
22.08.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.55
13.12.23
13.12.23
€112.13
13.12.24
13.12.24
9.59%
14.12.24
14.12.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€88.90
19.10.23
19.10.23
€109.69
19.10.24
19.10.24
23.73%
20.10.24
20.10.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.86
05.04.23
05.04.23
€124.25
05.04.24
05.04.24
8.89%
06.04.24
06.04.24